Hedge Fund - Broadfin Capital
Catalyst Pharmaceuticals Inc. (CPRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2019 - Q4 (2019-12-31) | $0 | 0% | 0 | $4.68 |
| 2 | 2019 - Q3 (2019-09-30) | $4,674,000 | 0.86% | 880,303 | $5.33 |
| 3 | 2019 - Q2 (2019-06-30) | $10,618,000 | 2.31% | 2,765,070 | $4.32 |
| 4 | 2019 - Q1 (2019-03-31) | $29,871,000 | 6.16% | 5,856,998 | $2.94 |
| 5 | 2018 - Q4 (2018-12-31) | $12,035,000 | 1.58% | 6,268,298 | $2.86 |
| 6 | 2018 - Q3 (2018-09-30) | $19,415,000 | 2.85% | 5,136,264 | $3.13 |
| 7 | 2018 - Q2 (2018-06-30) | $21,131,000 | 3.32% | 6,772,764 | $3.03 |
| 8 | 2018 - Q1 (2018-03-31) | $16,283,000 | 2.53% | 6,812,764 | $3.32 |
| 9 | 2017 - Q4 (2017-12-31) | $27,750,000 | 4.53% | 7,097,300 | $3.30 |
| 10 | 2017 - Q3 (2017-09-30) | $17,369,000 | 2.56% | 6,892,500 | $2.74 |
| 11 | 2017 - Q2 (2017-06-30) | $20,286,000 | 2.46% | 7,350,000 | $2.09 |
| 12 | 2017 - Q1 (2017-03-31) | $15,990,000 | 1.93% | 8,200,000 | $1.27 |
| 13 | 2016 - Q4 (2016-12-31) | $8,610,000 | 0.95% | 8,200,000 | $1.14 |
| 14 | 2016 - Q3 (2016-09-30) | $8,938,000 | 0.8% | 8,200,000 | $0.90 |
| 15 | 2016 - Q2 (2016-06-30) | $5,822,000 | 0.56% | 8,200,000 | $0.81 |
| 16 | 2016 - Q1 (2016-03-31) | $9,594,000 | 0.92% | 8,200,000 | $1.55 |
| 17 | 2015 - Q4 (2015-12-31) | $10,249,000 | 0.63% | 4,183,177 | $2.86 |
| 18 | 2015 - Q3 (2015-09-30) | $12,550,000 | 0.7% | 4,183,177 | $4.32 |
| 19 | 2015 - Q2 (2015-06-30) | $17,277,000 | 0.92% | 4,183,177 | $3.99 |
| 20 | 2015 - Q1 (2015-03-31) | $17,680,000 | 1.37% | 4,083,177 | $3.60 |
| 21 | 2014 - Q4 (2014-12-31) | $7,128,000 | 0.61% | 2,400,000 | $2.74 |
| 22 | 2014 - Q3 (2014-09-30) | $4,648,000 | 0.48% | 1,400,000 | $2.61 |
| 23 | 2014 - Q2 (2014-06-30) | $6,072,000 | 0.6% | 2,400,000 | $2.14 |
The displayed share prices are average quarterly stock market prices.